AzTrials
AzTrials

GeriatricsPROUSTNCT02421133

Impact of a Transitional Care Program on 30-Day Hospital Readmissions for Elderly Patients Discharged From a Short Stay Geriatric Ward

A study testing Transitional care program. in people with Geriatrics, run by Hospices Civils de Lyon at 9 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In France, it has be estimated that the hospital readmission rate within 30 days of patients aged 75 or older is 14% (IC95% [12.0-16.7]), nearly a quarter being avoidable. There is evidence that interventions "bridging" the transition from hospital to home involving a dedicated professional (usually nurses) would be… Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
Geriatrics
What is being tested?
Transitional care program.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
630 participants
Where
9 sitesFrance
Study dates
Jul 2015to 30 Nov 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patient hospitalized for 48 hours or more in one of the acute geriatric service participating to the study.
  • Aged 75 or older.
  • Leaving at home and with home as the planned discharge after the admission.
  • At risk of hospital readmission emergency visit rates after discharge (if he has two or more of the following criteria (taken from the Triage Risk Screening Tool and from the 2013 French recommendation)).

Who cannot join

  • Patient leaving in a retirement home.
  • Patient hospitalized at home.
  • Patient leaving at home but at 30 km (18 miles) or more from the service of his index admission

Trial locations and contacts

9 sites in 1 country.

9 sites in 1 country

France9 sites
  • CH Gériatrique des Monts d'Or

    Albigny-sur-Saône, 69250

  • CH Bourg-en-Bresse

    Bourg-en-Bresse, 01012

  • Centre Hospitalier Alpes Léman

    Contamine-sur-Arve, 74130

  • Hôpital Édouard Herriot

    Lyon, 69437

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69495

  • CHG Annecy

    Pringy, 74374

  • CH Saint-Chamond

    Saint-Chamond, 42400

  • Clinique des portes du sud

    Vénissieux, 69200

  • CH Villefranche

    Villefranche, 69655

Other trials in France

About this study

Official title: Impact of a Transitional Care Program Involving an Advanced Practice Nurse on 30-Day Hospital Readmissions for Elderly Patients Discharged From a Short Stay Geriatric Ward (PROUST Study)

In France, it has be estimated that the hospital readmission rate within 30 days of patients aged 75 or older is 14% (IC95% [12.0-16.7]), nearly a quarter being avoidable. There is evidence that interventions "bridging" the transition from hospital to home involving a dedicated professional (usually nurses) would be most effective in reducing the risk of readmission, but the level of evidence of current studies is low. Our study aims to assess the impact of a program of transitional care from hospital to home for people of 75 years old or more admitted to acute care.

Read the detailed description

The study is a stepped wedge randomized cluster study. Intervention: The transition care program, involving a dedicated advanced practice nurse, will include: 1) during the patient's stay in hospital: an individualized needs-based comprehensive discharge plan and a transitional care record ; the notification of the primary care physician about inpatient care and hospital discharge; 2) the day of the discharge: specific explanations about the organization of home care provided by the transition care nurse to the patient; 3) during 4 weeks after discharge: monitoring patients and caregivers regularly through home visits and/or telephone contact,

Conditions
Geriatrics
Being tested
Transitional care program., standard care program
Keywords
Care transition program, Patient readmission, Transition Nurse, Stepped wedge, elderly

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transitional care program.Other

    During the patient's stay in hospital, the transition nurse creates a transitional care file including information about the patient (inpatient medical and nurse care plan, medications), the discharge plan, and the contact information of the relevant primary care providers. She notifies the patient's primary care physician of the date of the discharge to home, of the potential medical problems and of the discharge care plan; a primary care physician visit is planned the month following the discharge.

    The day of the hospital discharge: meeting with the patient to review the follow-up recommendations. The transition nurse verifies that the medications are prescribed accordingly with the discharge plan, that the patient and his caregiver understand the prescription and are informed with the planned appointments and the biological monitoring.

    During 4 weeks after the hospital discharge: follow-up by the transition nurse once a week, alternately by telephone and home visit.

  • standard care programOther

    The patients will be discharged according to the usual care plan of each participating hospital. The medical team does a medical and geriatric assessment of the patients according to the recommendations. The communication of information to the primary care providers (nurse, primary care physician…) is left to the discretion of the medical teams of the discharging hospitals, according to their habits of work.

Study groups in NCT02421133
Study groupRoleWhat they receive
Transitional care program.ExperimentalThe transitional care program from hospital to home will be implemented at three steps: during the patient's stay in hospital, the day of the discharge and during 4 weeks after discharge.
Receives: Other: Transitional care program.
standard care programOtherNo intervention liable to affect the care provided to the patients, the organization of care or the practices of health care professionals will be implemented during the control period (time steps without intervention).
Receives: Other: standard care program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 30-Day unscheduled hospital readmission or emergency visit rate after the index hospital discharge.

    Unscheduled hospital readmissions are hospitalizations that are not planned at the moment of the discharge (for example: hospitalization after an emergency visit or upon request of the primary care physician).

    Measured: Within 30 days after hospital discharge.

Secondary outcomes (10)
  1. Length of stay in the short stay geriatric ward (index hospitalization)

    Measured: Patients will be followed for the duration of hospital stay, an expected average between 2 days and 30 days

  2. Unscheduled hospital readmissions or emergency room visits

    Measured: Within 30 and 90 days after the index hospital discharge.

  3. Free-hospitalization survival

    Measured: Within 30 and 90 days after the index hospital discharge.

  4. Mortality rate

    Measured: Within 30 and 90 days after the index hospital discharge.

  5. Adverse events (i.e. falls)

    Measured: Within 30 days after the index hospital discharge.

  6. Quality of life.

    Measured with the French version of the EUROQOL-5D.

    Measured: Within 30 days after the index hospital discharge.

  7. Patients' satisfaction care transition programme

    Measured with the Care Transition Measure® questionnaire.

    Measured: Within 30 days after the index hospital discharge.

  8. Delay between the index hospital discharge and the implementation of home care.

    Measured: Within 30 days after the index hospital discharge.

  9. Number of contacts between the transition nurse and the primary care providers or the hospital providers after discharge

    Measured: Within 30 days after the index hospital discharge.

  10. Costs of unscheduled hospital readmission or emergency visit

    Hospital and community care costs after discharge

    Measured: 30 days after discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2015 (estimated)
  2. Study startJul 2015
  3. Primary completion30 Nov 2016
  4. Study completion30 Nov 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
630 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02421133
Sponsor's protocol ID
2014.874
Acronym
PROUST
Status last verified
Dec 2025
First submitted
9 Mar 2015
Last updated
19 Dec 2025
Results posted
No
Data monitoring committee
No

Publications

  • Occelli P, Touzet S, Rabilloud M, Ganne C, Poupon Bourdy S, Galamand B, Debray M, Dartiguepeyrou A, Chuzeville M, Comte B, Turkie B, Tardy M, Luiggi JS, Jacquet-Francillon T, Gilbert T, Bonnefoy M. Impact of a transition nurse program on the prevention of thirty-day hospital readmissions of elderly patients discharged from short-stay units: study protocol of the PROUST stepped-wedge cluster randomised trial. BMC Geriatr. 2016 Mar 3;16:57. doi: 10.1186/s12877-016-0233-2.

    PubMed 26940678

Questions about this trial

What is this clinical trial studying?

A study testing Transitional care program. in people with Geriatrics, run by Hospices Civils de Lyon at 9 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

30-Day unscheduled hospital readmission or emergency visit rate after the index hospital discharge. (time frame: Within 30 days after hospital discharge.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02421133, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in